US close: Stocks lower as Trump slaps tariffs on key trading partners
Major indices closed lower on Monday after Donald Trump slapped several key trading partners with tariffs, leading to fears ...
Vertex Pharmaceuticals (VRTX) Ascends While Market Falls: Some Facts to Note
In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $470.37, marking a +1.88% move from the previous day.
Vertex Pharmaceuticals Inc. stock underperforms Monday when compared to competitors despite daily gains
This was the stock's second consecutive day of gains.
stocknews6h
3 Genomic Stocks at the Forefront of Precision Medicine
Precision medicine is revolutionizing healthcare, and these genomic stocks are leading the way. Therefore, as this sector ...
1VRTX : Vertex Pharmaceuticals Unusual Options Activity
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...
3 Magnificent Stocks to Buy and Hold Forever
Some people are fair-weather friends; others are lifelong. It's a similar story with stocks. Some you might hold only ...
Vertex (VRTX) Surges 5.3%: Is This an Indication of Further Gains?
Vertex (VRTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...
Vertex stock price target raised to $550 at H.C. Wainwright
H.C. Wainwright analyst Andrew Fein increased the price target for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) to $550 from the previous $535, while maintaining a Buy rating on the stock.
Vertex Pharmaceuticals (VRTX) Set for Painless Gains After FDA Approval
Vertex Pharmaceuticals (VRTX) stock has performed strongly since the turn of the year, gaining 14.6% and vastly outperforming ...
Evercore ISI Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX)
Evercore ISI analyst Liisa Bayko maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) on January 31 and set a price ...